Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
09 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/09/3058128/0/en/ValoTx-Appoints-Marcella-Origgi-from-Johnson-Johnson-Innovation-as-CEO.html
10 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/10/3039464/0/en/Valo-Therapeutics-announces-EUR-19m-of-investment-funding-and-expanded-clinical-trials.html
06 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/06/2975782/18623/en/Lisata-Therapeutics-and-Valo-Therapeutics-Announce-Preclinical-Research-Collaboration.html
29 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/29/2787495/0/en/Valo-Therapeutics-Announces-Regulatory-Approval-to-Expand-Phase-I-Immuno-oncology-Trial-into-Sarcoma.html
10 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/10/2757151/0/en/Valo-Therapeutics-Announces-Acquisition-of-Bruker-Corporation-s-Latest-Mass-Spectrometer-Platform-for-Tumor-Antigen-Identification-with-ValoTx-s-PeptiCHIP-Technology.html
15 Jun 2023
// PHARMABIZ
ABOUT THIS PAGE